Although mAb806 and mAb175 decrease tumor growth in xenografts displaying mutant, overexpressed, or autocrine stimulated EGFR, neither antibody inhibits the in vitro growth of cells expressing wtEGFR.
MAb806 completely inhibits the ligand-associated stimulation of cells expressing EGFR (C271A/C283A).